The growth
of adhesion market is driven by the growth in the geriatric population and
corresponding age-related chronic diseases, epidemiological shift from
infectious to chronic diseases, growing volume of surgical procedures and
sports-related injuries, and increasing awareness about the medical
complications occurred due to post-surgical adhesion formation.
Adhesion Barrier Market Dynamics: Impact Analysis
1. Increasing Awareness About the Medical Implications of Adhesions
2. Increase in the Volume of Surgeries and Sports-Related Injuries
3. Rising Focus on Gel-Form Adhesion Barriers for Surgeries
The adhesion barrier market is valued at 536.6 Million in 2017 and is expected to grow at a CAGR of 7.2% during the forecast period (2018 to 2023), to reach to USD 806.4 Million by 2023.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global Adhesion Barrier market?
2. What are the drivers, restraints, opportunities, and challenges in the Adhesion Barrier Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Adhesion Barrier in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
By application, the market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.
North America and Europe to Dominate The Global Adhesion Barrier Market:
North America holds the largest share of this market in 2017. This is primarily due to the increase in the aging population, increasing number of soft tissue injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, and well-established healthcare services across North America.
On the other hand, Asia Pacific region is expected to grow at a higher CAGR during the forecast period. The rising healthcare expenditure in these regions, growing volume of surgical procedures, and growing awareness about adhesions and their complications are driving the growth of these markets.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Key Players in Adhesion Barrier Market and Growth Strategies Adopted by Them:
Johnson & Johnson (J&J) (US), Sanofi (France), and Baxter International (US) dominated the global market in 2017. Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Adhesion Barrier Market Dynamics: Impact Analysis
1. Increasing Awareness About the Medical Implications of Adhesions
2. Increase in the Volume of Surgeries and Sports-Related Injuries
3. Rising Focus on Gel-Form Adhesion Barriers for Surgeries
The adhesion barrier market is valued at 536.6 Million in 2017 and is expected to grow at a CAGR of 7.2% during the forecast period (2018 to 2023), to reach to USD 806.4 Million by 2023.
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global Adhesion Barrier market?
2. What are the drivers, restraints, opportunities, and challenges in the Adhesion Barrier Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Adhesion Barrier in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
By application, the market is segmented into gynecological surgeries, general/abdominal surgeries, cardiovascular surgeries, orthopedic surgeries, neurological surgeries, reconstructive surgeries, urological surgeries, and other surgeries (such as ear, nose, throat, and burn surgeries). The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.
North America and Europe to Dominate The Global Adhesion Barrier Market:
North America holds the largest share of this market in 2017. This is primarily due to the increase in the aging population, increasing number of soft tissue injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, and well-established healthcare services across North America.
On the other hand, Asia Pacific region is expected to grow at a higher CAGR during the forecast period. The rising healthcare expenditure in these regions, growing volume of surgical procedures, and growing awareness about adhesions and their complications are driving the growth of these markets.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
Key Players in Adhesion Barrier Market and Growth Strategies Adopted by Them:
Johnson & Johnson (J&J) (US), Sanofi (France), and Baxter International (US) dominated the global market in 2017. Some of the other players competing in this market are C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Comments
Post a Comment